Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
gad-209-fsp (1 trial)
gad-pev (1 trial)
mva-209-fsp (1 trial)
mva-pev (1 trial)
Neoplasms (Phase 1)
Trials (2 total)
Trial APIs (4 total)